These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7136251)

  • 1. [Immunopathology of porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1982 Jul; (7):19-23. PubMed ID: 7136251
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycological and serological studies of patients with porphyria cutanea tarda].
    Farkas B; Hunyadi J; Simon N
    Mykosen; 1982 Nov; 25(11):606-17. PubMed ID: 6757745
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda.
    Lim HW; Perez HD; Poh-Fitzpatrick M; Goldstein IM; Gigli I
    N Engl J Med; 1981 Jan; 304(4):212-6. PubMed ID: 7442746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunochemical parameters and blood-letting therapy in porphyria cutanea tarda (author's transl)].
    Schwartze G; Kühn G
    Dermatol Monatsschr; 1980 Jan; 166(1):19-23. PubMed ID: 7398963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic discoid erythematosus and porphyria cutanea tarda].
    Malina L; Jíra M
    Cas Lek Cesk; 1987 Dec; 126(52):1620-3. PubMed ID: 3442789
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA and porphyria cutanea tarda.
    Llorente L; Enríquez de Salamanca R; Campillo F; Peña ML
    Arch Dermatol Res; 1980; 269(2):209-10. PubMed ID: 7458411
    [No Abstract]   [Full Text] [Related]  

  • 8. Porphyria cutanea tarda associated with autoimmune hypothyroidism, vitiligo and alopecia universalis.
    Sabán J; Rodríguez-García JL; Gil J; País JR; Medina S
    Neth J Med; 1991 Dec; 39(5-6):350-2. PubMed ID: 1803247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased frequency of HLA-A3 in subjects with sporadic porphyria cutanea tarda.
    Edwards CQ; Griffen LM; Kushner JP
    Tissue Antigens; 1988 May; 31(5):250-3. PubMed ID: 3261053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel assocation between HLA and disease: porphyria cutanea tarda and HLA-AW32.
    Santoianni P; De Felice M; Ayala F; Budillon G; Zappacosta S
    Dermatologica; 1980; 160(6):371-5. PubMed ID: 7389968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A3 and -B7 in porphyria cutanea tarda.
    Kuntz BM; Goerz G; Merk H; Strohmeyer G; Brüster HT
    Tissue Antigens; 1984 Jul; 24(1):67-9. PubMed ID: 6484933
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological and biochemical findings in patients with porphyria cutanea tarda.
    Błaszczyk M; Daoud S; Chorzelski T; Jabłońska S; Sulej J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):757-62. PubMed ID: 7349094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific metabolic aspects and the HLA system in porphyria cutanea tarda].
    Santoianni P; Ayala F; Budillon G
    G Ital Dermatol Venereol; 1984; 119(3):145-8. PubMed ID: 6746005
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of porphyria cutanea tarda sclerodermiformis].
    Olszewska Z; Woźniak L; Dudek H
    Przegl Dermatol; 1971; 58(1):59-64. PubMed ID: 5554741
    [No Abstract]   [Full Text] [Related]  

  • 15. [The HLA system and porphyria cutanea tarda].
    Köstler E; Gebhardt B; Seebacher C
    Dtsch Z Verdau Stoffwechselkr; 1984; 44(2):95-100. PubMed ID: 6592073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda-like syndrome in hemodialyzed patients.
    Brivet F; Drüeke T; Guillemette J; Zingraff J; Crosnier J
    Nephron; 1978; 20(5):258-66. PubMed ID: 643142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a fractionated ESR and ESR in Matliev's modification for evaluating body reactivity and treatment effectiveness in the late form of porphyria cutanea].
    Tsygankova EP
    Vestn Dermatol Venerol; 1979 Dec; (12):49-51. PubMed ID: 525026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunohistological investigation of skin from the insolation zone in patients with porphyria cutanea tarda (author's transl)].
    Vlasín Z; Kratochvíl F
    Cesk Dermatol; 1977 Jan; 52(1):52-6. PubMed ID: 322873
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the complement system in patients with porphyrias after irradiation in vivo.
    Lim HW; Poh-Fitzpatrick MB; Gigli I
    J Clin Invest; 1984 Dec; 74(6):1961-5. PubMed ID: 6392339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.